Researchers unveil new cancer strategy that can stop tumors before resistance takes hold
Researchers have proposed a new cancer treatment strategy that involves switching therapies before tumors can develop resistance, potentially improving cure rates. Led by Dr. Robert Noble from St George's, University of London, the study suggests that timely changes in treatment could prevent cancer cells from evolving mutations that render them resistant. This approach aims to tackle one of the major challenges in cancer care, as traditional methods often allow tumors to regrow before changing therapies.